Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
Current Oncology · 2024
DOI: 10.3390/curroncol31040136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Sandeep R Sehdev und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: Health Services Accessibility. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ottawa Hospital Research Institute, Abbvie Canada, AstraZeneca, Gilead, Lilly, Merck and Novartis.
Abstract (Originalsprache)
Patient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, health technology assessment (HTA) and collective government price negotiation. These steps delay access and prevent health care providers from being able to prescribe optimal therapy. Eighteen Canadian oncology clinicians from the medicine, nursing and pharmacy professions met to develop consensus recommendations for defining reasonable government performance standards around process and timeliness to improve Canadian cancer patients’ access to best care. A modified Delphi methodology was used to identify consensus on 30 questions involving five themes: accountability, disparities, endpoints, timeliness, and cost-effectiveness. It was agreed that greater transparency is required across regulatory and HTA processes. Health professionals in oncology are frustrated for their patients because they are unable to deliver the modern guideline-supported therapies they want to provide due to delays in approval or funding. Canadian health care providers request improvements in timely access to life-saving therapeutics in line with other comparator countries. Clinicians expect urgent improvements in Canadian health systems to give our patients their best chance of survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
- Macdonald-Laurier Institute, Ottawa, ON K1N 7Z2, Canada.
- Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON P7B 6V4, Canada.
- Faculty of Health, York University, Toronto, ON M3J 1P3, Canada.
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
- Canadian Association of Nurses in Oncology/Association Canadienne des Infirmières en Oncologie, Vancouver, BC V6A 1B6, Canada.
ORCID-Profile: Sandeep R Sehdev, Nigel S B Rawson, Marcus O Butler, Sharlene Gill, Cyrus C Hsia, Rosalyn A Juergens, Mita Manna, Stephanie L Snow, Ralph P W Wong
Förderung
- Ottawa Hospital Research Institute
- Abbvie Canada, AstraZeneca, Gilead, Lilly, Merck and Novartis
Zitieren
APA
Sehdev, S. R., Rawson, N. S. B., Aseyev, O. I., Buick, C. J., Butler, M. O., Edwards, S., Gill, S., Gotfrit, J. M., Hsia, C. C., Juergens, R. A., Manna, M., McCarthy, J. S., Mukherjee, S. D., Snow, S. L., Spadafora, S., Stewart, D. J., Wentzell, J. R., Wong, R. P. W., & Zalewski, P. G. (2024). Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. https://doi.org/10.3390/curroncol31040136
Vancouver
Sehdev SR, Rawson NSB, Aseyev OI, Buick CJ, Butler MO, Edwards S, et al. Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. 2024. doi:10.3390/curroncol31040136
BibTeX
@article{Sehdev2024,
author = {Sehdev, Sandeep R and Rawson, Nigel S B and Aseyev, Olexiy I and Buick, Catriona J and Butler, Marcus O and Edwards, Scott and Gill, Sharlene and Gotfrit, Joanna M and Hsia, Cyrus C and Juergens, Rosalyn A and Manna, Mita and McCarthy, Joy S and Mukherjee, Som D and Snow, Stephanie L and Spadafora, Silvana and Stewart, David J and Wentzell, Jason R and Wong, Ralph P W and Zalewski, Pawel G},
title = {Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31040136}
}
EUVIMED